Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection

Abstract Curative resection is recommended for patient with early stage hepatocellular carcinoma (HCC), however, the prognosis is limited by high recurrence rate. This study was to investigate liver stiffness (LS) and metabolic factor in prediction of HCC recurrence for patients with early stage HCC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jing-Houng Wang, Wei-Feng Li, Chee-Chien Yong, Yueh-Wei Liu, Sheng-Nan Lu, Chih-Chi Wang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/95d77efd1f2c40c8be2deff93a65e991
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:95d77efd1f2c40c8be2deff93a65e991
record_format dspace
spelling oai:doaj.org-article:95d77efd1f2c40c8be2deff93a65e9912021-12-02T16:31:07ZLiver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection10.1038/s41598-021-85431-y2045-2322https://doaj.org/article/95d77efd1f2c40c8be2deff93a65e9912021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85431-yhttps://doaj.org/toc/2045-2322Abstract Curative resection is recommended for patient with early stage hepatocellular carcinoma (HCC), however, the prognosis is limited by high recurrence rate. This study was to investigate liver stiffness (LS) and metabolic factor in prediction of HCC recurrence for patients with early stage HCC who had undergone curative resection. Consecutive patients with suspicion of HCC who had undergone curative resection were prospectively enrolled. Transient elastography was performed to determine LS pre-operatively. The demographics, clinical characteristics and histological findings were recorded. All patients were followed up regularly until recurrence, death or last visit. Ninety-four patients with early stage HCC were enrolled. LS positively correlated with fibrosis stage (r = 0.666). In a median follow-up of 3.2 years, forty patients developed recurrences including 22 recurrences after 1-year post resection. The 5-year cumulative recurrence rate was 44.2%. LS was the independent factor associated with recurrence. Patients with LS > 8.5 kPa had higher 5-year cumulative recurrence rate (59.8% vs 25.1%, p = 0.007). For the prediction of recurrence after 1-year post resection, LS > 8.5 kPa (hazard ratio 2.72) and homeostatic model assessment for insulin resistance index (HOMA-IR) (hazard ratio 1.24) were independent factors in multivariate analysis. Those patients with both LS > 8.5 kPa and HOMA-IR > 2.3 had the highest recurrence rate after 1-year post resection.Jing-Houng WangWei-Feng LiChee-Chien YongYueh-Wei LiuSheng-Nan LuChih-Chi WangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jing-Houng Wang
Wei-Feng Li
Chee-Chien Yong
Yueh-Wei Liu
Sheng-Nan Lu
Chih-Chi Wang
Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
description Abstract Curative resection is recommended for patient with early stage hepatocellular carcinoma (HCC), however, the prognosis is limited by high recurrence rate. This study was to investigate liver stiffness (LS) and metabolic factor in prediction of HCC recurrence for patients with early stage HCC who had undergone curative resection. Consecutive patients with suspicion of HCC who had undergone curative resection were prospectively enrolled. Transient elastography was performed to determine LS pre-operatively. The demographics, clinical characteristics and histological findings were recorded. All patients were followed up regularly until recurrence, death or last visit. Ninety-four patients with early stage HCC were enrolled. LS positively correlated with fibrosis stage (r = 0.666). In a median follow-up of 3.2 years, forty patients developed recurrences including 22 recurrences after 1-year post resection. The 5-year cumulative recurrence rate was 44.2%. LS was the independent factor associated with recurrence. Patients with LS > 8.5 kPa had higher 5-year cumulative recurrence rate (59.8% vs 25.1%, p = 0.007). For the prediction of recurrence after 1-year post resection, LS > 8.5 kPa (hazard ratio 2.72) and homeostatic model assessment for insulin resistance index (HOMA-IR) (hazard ratio 1.24) were independent factors in multivariate analysis. Those patients with both LS > 8.5 kPa and HOMA-IR > 2.3 had the highest recurrence rate after 1-year post resection.
format article
author Jing-Houng Wang
Wei-Feng Li
Chee-Chien Yong
Yueh-Wei Liu
Sheng-Nan Lu
Chih-Chi Wang
author_facet Jing-Houng Wang
Wei-Feng Li
Chee-Chien Yong
Yueh-Wei Liu
Sheng-Nan Lu
Chih-Chi Wang
author_sort Jing-Houng Wang
title Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
title_short Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
title_full Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
title_fullStr Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
title_full_unstemmed Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
title_sort liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/95d77efd1f2c40c8be2deff93a65e991
work_keys_str_mv AT jinghoungwang liverstiffnessandinsulinresistanceinpredictingrecurrenceforearlystagehepatomapatientsaftercurativeresection
AT weifengli liverstiffnessandinsulinresistanceinpredictingrecurrenceforearlystagehepatomapatientsaftercurativeresection
AT cheechienyong liverstiffnessandinsulinresistanceinpredictingrecurrenceforearlystagehepatomapatientsaftercurativeresection
AT yuehweiliu liverstiffnessandinsulinresistanceinpredictingrecurrenceforearlystagehepatomapatientsaftercurativeresection
AT shengnanlu liverstiffnessandinsulinresistanceinpredictingrecurrenceforearlystagehepatomapatientsaftercurativeresection
AT chihchiwang liverstiffnessandinsulinresistanceinpredictingrecurrenceforearlystagehepatomapatientsaftercurativeresection
_version_ 1718383888088170496